SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,541 INR | +0.62% |
|
+1.04% | +22.35% |
| 09/05 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
| 08/05 | Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner Secunderabad, Telangana | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 486B 5.83B | Sales 2025 * | 539B 6.47B | Capitalization | 3,676B 44.15B |
|---|---|---|---|---|---|
| Net income 2024 * | 93.06B 1.12B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.37 x |
| Net cash position 2024 * | 97.98B 1.18B | Net cash position 2025 * | 161B 1.94B | EV / Sales 2025 * | 6.52 x |
| P/E ratio 2024 * |
39.2
x | P/E ratio 2025 * |
32.6
x | Employees | 41,000 |
| Yield 2024 * |
0.81% | Yield 2025 * |
0.94% | Free-Float | 45.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sun Pharmaceutical Industries Ltd.
More recommendations
More press releases
More news
| 1 day | +1.41% | ||
| 1 week | +0.50% | ||
| Current month | +3.39% | ||
| 1 month | +0.83% | ||
| 3 months | +0.62% | ||
| 6 months | +29.26% | ||
| Current year | +23.30% |
1 week
1 508.30
1 558.30
1 month
1 477.701 562.45
Current year
1 257.151 638.85
1 year
922.851 638.85
3 years
652.701 638.85
5 years
312.001 638.85
10 years
312.001 638.85
| Managers | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Founder | 68 | 01/82/01 | |
| Director of Finance/CFO | - | 19/17/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 68 | 01/82/01 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/21/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15/23/15 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.72% | 6 M€ | +6.07% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/24/21 | 1,541 | +0.62% | 1 791 791 |
| 18/24/18 | 1,532 | +0.03% | 51,458 |
| 17/24/17 | 1,531 | -0.32% | 1,341,676 |
| 16/24/16 | 1,536 | +0.58% | 2,684,392 |
| 15/24/15 | 1,527 | -1.16% | 1,207,536 |
Delayed Quote NSE India S.E., May 21, 2024 at 02:19 pm IST
More quotes
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
22/05/2024
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,532
INR
Average target price
1,575
INR
Spread / Average Target
+2.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.30% | 44.12B | |
| +22.22% | 22.61B | |
| +18.18% | 15.11B | |
| +15.70% | 13.61B | |
| +60.66% | 13.34B | |
| -8.98% | 6.94B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +15.65% | 5.75B | |
| +6.11% | 4.78B |
- Stock Market
- Equities
- SUNPHARMA Stock
